Sunday, March 09, 2014

Lisa Emrich's Posts

MS Awareness Month 2014 and Telling Your Story

Each March is MS Awareness Month in the US and March 3-9, 2014, is MS Awareness Week!!  It is a great time to tell your story to educate and spread awareness of the disease and to bring hope and inspiration (provide comfort and courage) to others whose lives have been touched by multiple sclerosis. Next week in Washington, DC, hundreds of MS... Read moreChevron

Hot Topics and MS Research News for February 2014

Aubagio approved in the UK for MS: Previously approved by the FDA in September 2012, the oral MS drug teriflunomide (Aubagio) has now been accepted for use in the United Kingdom (UK) National Health Service by the National Institute for Health and Care Excellence (NICE) for the treatment of patients with relapsing-remitting MS. ... Read moreChevron

Identifying the Effects of Stress on MS

Stress is a daily fact of life.  It is our response to stressors which can be healthy or harmful.  Stress helps to keep us focused.  In response to situations which are perceived to be potentially dangerous, stress hormones, such as cortisol, adrenaline, and epinephrine, are released by the adrenal glands.  This is part of the... Read moreChevron

MS Relapses: Causes, Symptoms and Treatments

The majority of people diagnosed with multiple sclerosis have a relapsing form of the disease, characterized by unpredictable episodes (called relapses or exacerbations) of acute worsening of neurologic function. During a relapse, you might experience new symptoms and/or a worsening of previous or existing symptoms.   What causes a... Read moreChevron

Can Medical Marijuana Help Control MS Symptoms?: A HealthCentral Explainer

The use of medical marijuana remains a hot topic in the United States.  Although twenty states and the District of Columbia have enacted laws to legalize medical marijuana, in the majority of the country, marijuana is still an illicit drug.  In the MS community, the patient advocacy organizations are generally neutral on the subject:... Read moreChevron